Evaluation of Cellular Targeting by Fab′ vs Full-Length Antibodies in Antibody–Nanoparticle Conjugates (ANCs) Using CD4 T-cells-Reference-Cited by-同舟云学术

Evaluation of Cellular Targeting by Fab′ vs Full-Length Antibodies in Antibody–Nanoparticle Conjugates (ANCs) Using CD4 T-cells

Published:2022-02-09 Issue:3 Volume:33 Page:486-495
ISSN:1043-1802
Container-title:Bioconjugate Chemistry
language:en
Short-container-title:Bioconjugate Chem.

Author:

Singh Khushboo¹²,Canakci Mine¹³⁴,Kanjilal Pintu¹²,Williams Natalie¹,Shanthalingam Sudarvili³,Osborne Barbara A.²³⁴,Thayumanavan S.¹²⁴⁵^ORCID

Affiliation:

1. Department of Chemistry, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States

2. Center for Bioactive Delivery, Institute for Applied Life Sciences University of Massachusetts, Amherst, Amherst, Massachusetts 01003, United States

3. Department of Veterinary and Animal Sciences, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States

4. Molecular and Cellular Biology Program, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States

5. Department of Biomedical Engineering, University of Massachusetts Amherst, Amherst, Massachusetts 01003, United States

Funder

National Institute of General Medical Sciences

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.2c00024

Reference44 articles.

1. The oncology market for antibody–drug conjugates

2. Recent advances of antibody drug conjugates for clinical applications

3. Arming antibodies for cancer therapy

4. Arming antibodies: prospects and challenges for immunoconjugates

5. Nanoparticles in the clinic: An update

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical considerations of mRNA–LNP technology for CAR-T therapy: components, payloads and emerging horizons;Materials Chemistry Frontiers;2024

2. Advanced nanomedicines for the treatment of age-related macular degeneration;Nanoscale;2024

3. Impact of Targeting Moiety Type and Protein Corona Formation on the Uptake of Fn14-Targeted Nanoparticles by Cancer Cells;ACS Nano;2023-10-09

4. Coiled-Coil-Based Biofunctionalization of 100 nm Gold Nanoparticles with the Trastuzumab Antibody for the Detection of HER2-Positive Cancer Cells;Langmuir;2023-08-15

5. Antibody Polymer Conjugates (APCs) for Active Targeted Therapeutic Delivery;Biomacromolecules;2023-07-21